ArticleAnnals of medicine2024

Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China.

You Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.